Advances in the diagnosis and treatment of fungal infections of the CNS
S Schwartz, DP Kontoyiannis, T Harrison… - The Lancet …, 2018 - thelancet.com
Fungal infections of the CNS are challenging to treat and their optimal management requires
knowledge of their epidemiology, host characteristics, diagnostic criteria, and therapeutic …
knowledge of their epidemiology, host characteristics, diagnostic criteria, and therapeutic …
Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients
Introduction: Multiple sclerosis (MS) is an immune-mediated and neurodegenerative
disease with an unpredictable outcome. Immune-modulatory treatment aims at decreasing …
disease with an unpredictable outcome. Immune-modulatory treatment aims at decreasing …
Safety of newer disease modifying therapies in multiple sclerosis
G Jalkh, R Abi Nahed, G Macaron, M Rensel - Vaccines, 2020 - mdpi.com
In the past decade, the therapeutic arsenal for multiple sclerosis has expanded greatly.
Newer more potent disease modifying therapies (DMTs) with varying mechanisms of actions …
Newer more potent disease modifying therapies (DMTs) with varying mechanisms of actions …
T cell infiltration into the brain triggers pulmonary dysfunction in murine Cryptococcus-associated IRIS
T Kawano, J Zhou, S Anwar, H Salah, AH Dayal… - Nature …, 2023 - nature.com
Cryptococcus-associated immune reconstitution inflammatory syndrome (C-IRIS) is a
condition frequently occurring in immunocompromised patients receiving antiretroviral …
condition frequently occurring in immunocompromised patients receiving antiretroviral …
New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis
E Temfack, T Boyer-Chammard, D Lawrence… - Current neurology and …, 2019 - Springer
Abstract Purpose of Review Defective cell–mediated immunity is a major risk factor for
cryptococcosis, a fatal disease if untreated. Cryptococcal meningitis (CM), the main …
cryptococcosis, a fatal disease if untreated. Cryptococcal meningitis (CM), the main …
Anti–PD-1 antibody treatment promotes clearance of persistent cryptococcal lung infection in mice
JA Roussey, SP Viglianti… - The Journal of …, 2017 - journals.aai.org
Activation of immunomodulatory pathways in response to invasive fungi can impair
clearance and promote persistent infections. The programmed cell death protein-1 (PD-1) …
clearance and promote persistent infections. The programmed cell death protein-1 (PD-1) …
Infections and multiple sclerosis: recommendations from the French Multiple Sclerosis Society
C Papeix, C Donze, C Lebrun-Frénay, C Donzé… - Revue …, 2021 - Elsevier
Introduction Viral, bacterial, or fungal infections are suspected of triggering multiple sclerosis
(MS) and promoting relapses of the disease and are likely to be promoted by immune-active …
(MS) and promoting relapses of the disease and are likely to be promoted by immune-active …
Cryptococcal meningitis reported with fingolimod treatment: case series
M Del Poeta, BJ Ward, B Greenberg… - Neurology …, 2022 - AAN Enterprises
Background and Objectives To describe the characteristics of patients with MS reporting
cryptococcal meningitis (CM) while treated with fingolimod. Methods The Novartis safety …
cryptococcal meningitis (CM) while treated with fingolimod. Methods The Novartis safety …
Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment
S Otero-Romero, A Sánchez-Montalvá… - Expert Review of …, 2021 - Taylor & Francis
Introduction: The important development that the multiple sclerosis (MS) treatment field has
experienced in the last years comes along with the need of dealing with new adverse events …
experienced in the last years comes along with the need of dealing with new adverse events …
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review
R Scotto, A Reia, AR Buonomo, M Moccia… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Disease modifying treatments are commonly used in the treatment of multiple
sclerosis. As different opportunistic infections have been reported, concerns are also raised …
sclerosis. As different opportunistic infections have been reported, concerns are also raised …